Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study

AIMS/HYPOTHESIS: Concerns have been raised regarding a potential association of use of the incretin-based drugs dipeptidyl peptidase 4 (DPP4) inhibitors and glucagon-like peptide-1 (GLP-1)-receptor agonists with risk of cholangiocarcinoma. We examined this association in nationwide data from three c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueda, Peter, Wintzell, Viktor, Melbye, Mads, Eliasson, Björn, Svensson, Ann-Marie, Franzén, Stefan, Gudbjörnsdottir, Soffia, Hveem, Kristian, Jonasson, Christian, Svanström, Henrik, Pasternak, Björn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423638/
https://www.ncbi.nlm.nih.gov/pubmed/34254177
http://dx.doi.org/10.1007/s00125-021-05508-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423638/
https://www.ncbi.nlm.nih.gov/pubmed/34254177
http://dx.doi.org/10.1007/s00125-021-05508-1

Ejemplares similares